This meeting has been organised by CliniLink Ltd and sponsored through funding by Daiichi Sankyo UK Ltd. Daiichi Sankyo UK Ltd has not been involved in the organisation of this meeting except for the sponsored symposium, for which Daiichi Sankyo UK Ltd is fully responsible.
Why Is It Important to Get LDL-C and Non-HDL-C as Low as Possible? (Virtual)
This meeting has been organised by CliniLink Ltd and is supported by pharmaceutical companies through sponsorship. The sponsors were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting. Further information about the event and sponsorship can be found below
This meeting has been organised by CliniLink Ltd and sponsored through funding by Daiichi Sankyo UK Ltd. Daiichi Sankyo UK Ltd has not been involved in the organisation of this meeting except for the sponsored symposium, for which Daiichi Sankyo UK Ltd is fully responsible.
See Sponsors below
£0.00
WEBINAR
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: MS Teams
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 19:00-19:05 | Welcome and Introduction | CliniLink |
| 19:05-19:35 | This promotional symposium has been organised and funded by Daiichi Sankyo UK Ltd and is intended for UK healthcare professionals only. Daiichi Sankyo medicines will be discussed. Daiichi Sankyo has had no involvement in the organisation of this meeting other than the sponsored symposium | Daiichi Sankyo UK Ltd |
| 19:35-20:20 | Why is it important to get LDL & non-HDL as low as possible? Explore the evidence behind intensive lipid lowering, the role of LDL-C and non-HDL-C in atherosclerosis, and why earlier intervention can significantly reduce cardiovascular risk. | Professor Ahmet Fuat |
| 20:20-21:00 | Question and Answer | ALL |
Webinar Summary
Cardiovascular disease remains a leading cause of morbidity and mortality, yet many events are preventable through earlier identification and effective lipid management. This webinar will examine the role of LDL-C and non-HDL-C in the development of atherosclerotic cardiovascular disease (ASCVD) and review the evidence supporting intensive lipid lowering. Delegates will gain practical insights into current guideline recommendations, treatment targets, and strategies to optimise lipid management in primary care to improve long-term patient outcomes.
Learning Outcomes
By the end of this webinar, participants will be able to:
- Understand the role of LDL-C and non-HDL-C in the development of ASCVD.
- Explain why earlier and intensive lipid lowering reduces cardiovascular risk.
- Apply current guideline recommendations and lipid targets in clinical practice.
- Optimise lipid-lowering therapy to improve long-term cardiovascular outcomes.
Key Benefits
- Practical, case-based learning focused on lipid management in primary care.
- Evidence-based guidance aligned with current UK and European guidelines.
- Improve confidence in assessing cardiovascular risk and optimising lipid-lowering therapy.
- Understand how earlier and intensive LDL-C reduction improves patient outcomes.
- Opportunity to ask questions during the live Q&A session.
- CPD-accredited with a certificate of attendance.
Additional Information
- Suitable for GPs, prescribing pharmacists, nurses, physician associates, and other primary care healthcare professionals.
- Free to attend, but advance registration is required.
Meet the Speaker
Professor Ahmet Fuat
PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP CardiologyHonorary Professor, Durham University · GP & GPSI Cardiology (25+ years) · National Programme Director, CliniLink
A Darlington GP for 40 years and one of the UK’s leading voices in primary care cardiology. Professor Fuat established the UK’s first one-stop integrated heart failure clinic in 2002, earned his PhD researching heart failure diagnosis and natriuretic peptides, and has shaped NICE and ESC guidelines on CVD and heart failure — with his HF work featured in the BHF Blueprint for Heart Failure.
Fellow of the RCGP, RCP London, RCP Edinburgh, the ESC and the PCCS, he sits on the editorial boards of the British Journal of Cardiology and the Primary Care Cardiovascular Journal. He teaches because translating evidence into everyday practice is where patient care is won.
Symposium Sponsor
